Also trades as: AVCR.V (TSXV) · $vol 0M
AVCRF OTC
Avricore Health Inc.
1W: +0.0%
1M: -96.8%
3M: -97.7%
YTD: -97.5%
1Y: -98.3%
3Y: -99.6%
5Y: -99.5%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$5M
+37.3% ▲
5Y CAGR: +170.6%
Gross Profit
$2M
+56.2% ▲
5Y CAGR: +164.6%
Operating Income
$182K
+126.5% ▲
Net Income
-$669K
+4.6% ▲
EPS (Diluted)
$-0.01
-42.9% ▼
EBITDA
$629K
+323.8% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $33K | $123K | $2M | $3M | $5M |
| YoY Growth | +0.1% | +271.8% | +1340.0% | +97.1% | +37.3% |
| Cost of Revenue | $16K | $92K | $1M | $2M | $3M |
| Gross Profit | $17K | $31K | $457K | $1M | $2M |
| Gross Margin | 52.9% | 24.9% | 25.8% | 34.5% | 39.3% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $848K | $2M | $1M | $2M | $2M |
| Operating Expenses | $871K | $2M | $1M | $2M | $2M |
| Operating Income | -$859K | -$2M | -$810K | -$687K | $182K |
| Operating Margin | -2601.1% | -1420.9% | -45.8% | -19.7% | 3.8% |
| Interest Expense | $159K | $38K | $8K | $3K | $0 |
| Income Before Tax | -$1M | -$2M | -$818K | -$701K | -$669K |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$1M | -$2M | -$827K | -$701K | -$669K |
| Net Margin | -4035.5% | -1422.2% | -46.7% | -20.1% | -14.0% |
| EPS (Diluted) | $-0.02 | $-0.02 | $-0.01 | $-0.01 | $-0.01 |
| EBITDA | -$930K | -$2M | -$635K | -$281K | $629K |
| Shares Outstanding | 60M | 93M | 98M | 100M | 100M |